BioArctic AB Class B · GETTEX:B9A

BioArctic AB Class B financial statements

BioArctic AB Class B's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in SEK

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue2.00B257.4M616.0M228.3M23.1M62.3M281.8M714.0M140.7M105.6M
Cost of revenue59.2M27.0M15.0M74.3M55.1M50.2M72.4M145.4M266.0K238.0K
Gross profit1.94B230.4M601.0M154.0M-31.9M12.1M209.4M568.6M140.4M105.4M
Research and development376.9M311.1M172.1M74.3M55.1M50.2M72.4M145.4M101.6M53.7M
Selling, general and administrative115.7M93.4M128.5M115.7M24.9M23.4M31.2M31.9M31.5M14.5M
Operating income1.26B-228.5M252.6M-10.2M-139.7M-82.3M112.5M488.8M19.3M74.6M
Depreciation and amortization12.8M10.7M18.4M14.6M13.1M10.9M9.20M2.06M1.99M1.56M
EBITDA1.27B-217.8M271.1M4.47M-126.6M-71.4M121.7M490.9M21.3M76.2M
Interest expense37.9M1.85M10.4M2.12M984.0K1.10M1.19M1.37M647.0K5.00K
Income before tax1.26B-189.5M276.5M-11.2M-140.5M-86.7M113.0M489.6M19.7M74.1M
Income tax233.3M-12.4M47.2M11.0K-20.7M-18.2M24.5M108.0M4.53M16.6M
Net income1.02B-177.1M229.2M-11.2M-119.8M-68.5M88.5M381.6M15.2M57.6M
Earnings per share, basic1,155,000.00-200,000.00260,000.00-0.13-1.36-0.781.004.330.170.65
Earnings per share, diluted1,152,000.00-200,000.00259,000.00-13.00

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents1.04B512.9M611.6M805.4M848.4M999.9M1.11B917.3M1.11B692.5M
Short-term investments1.15B266.0M500.0M
Receivables121.6M71.2M223.0K02.84M5.60M28.7M462.3M17.3M634.0K
Inventory-223.0K7.50M12.94M-462.3M2.81M-634.0K
Current assets2.49B1.01B1.15B820.8M861.8M1.01B1.14B1.38B1.13B699.5M
Property, plant and equipment36.9M39.5M23.5M23.5M17.0M39.9M37.1M9.29M7.09M5.64M
Total assets2.58B1.11B1.19B858.3M897.7M1.05B1.18B1.39B1.14B708.0M
Accounts payable23.9M50.5M29.9M21.5M11.8M14.3M8.22M14.8M7.59M11.7M
Current liabilities520.8M175.7M125.0M70.9M101.3M108.7M149.2M342.8M498.9M643.1M
Total debt44.1M54.2M4.98M10.0M15.9M20.8M27.4M
Total liabilities608.1M216.7M139.5M72.1M109.1M143.0M208.8M375.3M504.3M647.2M
Shareholders' equity1.97B894.9M1.05B786.2M788.7M907.3M974.5M1.02B636.1M60.8M
Shares outstanding88.7M88.5M88.5M88.1M88.1M88.1M88.1M88.1M88.1M88.1M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations1.43B-316.3M309.7M-31.6M-140.5M-92.3M327.2M-200.1M-135.3M675.1M
Capital spending-10.2M-26.6M-7.44M-12.7M-4.39M-12.5M-3.26M-4.25M-3.45M-2.97M
Free cash flow1.42B-343.0M302.3M-44.4M-144.8M-104.8M323.9M-204.3M-138.8M672.2M
Cash from investing-894.6M205.6M-507.5M-12.8M-4.41M-12.5M-3.27M-3.08M-2.81M-2.97M
Cash from financing26.9M5.69M14.1M-2.81M-7.39M-6.60M-138.5M-138.5M560.2M-105.1M
Dividends paid-26.0M-6.02M-15.0M-5.99M00-132.1M-132.1M-132.1M-105.1M
Share buybacks6.02M15.0M5.99M0560.2M
Change in cash563.3M-105.0B-183.7B-47.2B-152.3M-112.8M195.5M-193.1M417.8M578.7M